CardioClinique: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CardioClinique
Largest movements
- Deferred charges and accrued income +€29,511
up €29,511 (+1,317%), from €2,240 to €31,751
- Cash +€28,979
up €28,979 (+294%), from €9,865 to €38,844
mainly Net result for the year (+€49,513) and Tax, wage and social debts (+€9,945)
- Tangible fixed assets +€3,220
up €3,220 (+52.5%), from €6,133 to €9,353
of which Assets under construction and advance payments: +€4,455
- Profit (loss) carried forward +€49,513
up €49,513 (+1,012%), from €4,892 to €54,405
- Tax, wage and social debts +€9,945
up €9,945 (+787%), from €1,263 to €11,208
- Trade debts +€7,306
up €7,306 (+270%), from €2,710 to €10,016
- Other debts -€5,054
down €5,054 (-79.3%), from €6,373 to €1,319
- Gross operating margin +€58,081
up €58,081 (+937%), from €6,199 to €64,279
- Taxes +€11,945
up €11,945 (+946%), from €1,263 to €13,208
- Depreciation +€1,367
up €1,367 (+3,116%), from €44 to €1,411
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €18,238 | €79,949 | +€61,711 | +338% |
| Fixed assets | 21/28 | €6,133 | €9,353 | +€3,220 | +52.5% |
| Tangible fixed assets | 22/27 | €6,133 | €9,353 | +€3,220 | +52.5% |
| Furniture and vehicles | 24 | €6,133 | €4,898 | -€1,235 | -20.1% |
| Assets under construction and advance payments | 27 | - | €4,455 | +€4,455 | |
| Current assets | 29/58 | €12,105 | €70,596 | +€58,491 | +483% |
| Cash at bank and in hand | 54/58 | €9,865 | €38,844 | +€28,979 | +294% |
| Deferred charges and accrued income | 490/1 | €2,240 | €31,751 | +€29,511 | +1,317% |
| Total equity and liabilities | 10/49 | €18,238 | €79,949 | +€61,711 | +338% |
| Equity | 10/15 | €7,892 | €57,405 | +€49,513 | +627% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €4,892 | €54,405 | +€49,513 | +1,012% |
| Amounts payable | 17/49 | €10,346 | €22,543 | +€12,197 | +118% |
| Amounts payable within one year | 42/48 | €10,346 | €22,543 | +€12,197 | +118% |
| Trade debts | 44 | €2,710 | €10,016 | +€7,306 | +270% |
| Suppliers | 440/4 | €2,710 | €10,016 | +€7,306 | +270% |
| Taxes, remuneration and social security | 45 | €1,263 | €11,208 | +€9,945 | +787% |
| Taxes | 450/3 | €1,263 | €11,208 | +€9,945 | +787% |
| Other amounts payable | 47/48 | €6,373 | €1,319 | -€5,054 | -79.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €44 | €1,411 | +€1,367 | +3,116% |
| Other operating charges | 640/8 | - | €50 | +€50 | |
| Gross operating margin | 9900 | €6,199 | €64,279 | +€58,081 | +937% |
| Operating profit (loss) | 9901 | €6,155 | €62,818 | +€56,663 | +921% |
| Financial charges | 65/66B | - | €97 | +€97 | |
| Recurring financial charges | 65 | - | €97 | +€97 | |
| Profit (loss) for the period before taxes | 9903 | €6,155 | €62,721 | +€56,566 | +919% |
| Income taxes | 67/77 | €1,263 | €13,208 | +€11,945 | +946% |
| Profit (loss) for the period | 9904 | €4,892 | €49,513 | +€44,622 | +912% |
| Profit (loss) for the period to be appropriated | 9905 | €4,892 | €49,513 | +€44,622 | +912% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.